Gallic acid attenuates diabetic cardiomyopathy by inhibiting ferroptosis and protecting mitochondria via the TSPO/FTMT pathway
GA was shown to attenuate diabetic cardiomyopathy by inhibiting ferroptosis and protecting mitochondria via the TSPO/FTMT signaling pathway.
Authors
- Fajia Hu (ORCID: https://orcid.org/0000-0003-3758-8939)
- Xiuqi Wang (ORCID: https://orcid.org/0000-0003-2033-9485)
- Lanxiang Liu (ORCID: https://orcid.org/0000-0002-7434-4434)
- Huashan Xu (ORCID: https://orcid.org/0000-0002-2476-9573)
- Hua-Xi Zou (ORCID: https://orcid.org/0000-0002-5046-8678)
- Songqing Lai (ORCID: https://orcid.org/0000-0002-6234-4154)
- Huang Huang (ORCID: https://orcid.org/0000-0001-8202-0061)
- Zheyu Zhang (ORCID: https://orcid.org/0000-0003-1352-2310)
- Jichun Liu
- Chenchao Zou
- Yuxian Yu
Institutions
- Nanchang University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Second Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-12-03
- DOI
- https://doi.org/10.3389/fphar.2025.1661144
- Citations
- 1
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- National Natural Science Foundation of China